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Abstract
Objective—To evaluate the impact of an episode of intermenstrual bleeding on the probability of 
conception in a menstrual cycle (fecundability).
Design—Prospective, time to pregnancy cohort study
Setting—Community-based cohort
Patient(s)—Women trying to conceive, ages 30-44 years, without known infertility
Intervention(s)—None
Main Outcome Measure(s)—Current cycle and subsequent cycle fecundability
Result(s)—A total of 549 women provided 1,552 complete cycles for analysis. Intermenstrual 
and luteal bleeding were reported in 36% and 34% of cycles, respectively. Ninety-three percent of 
all intermenstrual bleeding was luteal. Cycles in which women had intermenstrual bleeding or 
luteal bleeding were significantly less likely to result in conception (fecundability ratio (FR)=0.23, 
95% Confidence Interval (CI): 0.16-0.34 and FR=0.22, 95% CI:0.14-0.33 ). Women with an 
episode of intermenstrual and luteal bleeding had a significant increase in probability of pregnancy 
in the subsequent cycle (FR=1.61, 95% CI:1.15-2.25 and FR=2.01, 95%CI:1.52-2.87, 
respectively).
Conclusion(s)—Intermenstrual bleeding significantly decreases the odds of conceiving in that 
cycle; however, it does not appear to negatively impact a woman’s immediate future reproductive 
potential.
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Introduction
Menses occurs as a response to the late luteal phase drop in progesterone after failure of the 
corpus luteum (1-4). Bleeding during the cycle at a time separate from menses, known as 
intermenstrual bleeding, is relatively common (5-7). Intermenstrual bleeding is thought to be 
caused by structural abnormalities or hormonal imbalances. Possible structural abnormalities 
include uterine polyps or fibroids. Hormonal imbalances include luteal phase defects 
attributed to poor corpus luteal development and inadequate progesterone secretion.
These underlying pathologies, which manifest themselves in intermenstrual bleeding, may 
interfere with fertility. Structural abnormalities, such as uterine polyps and fibroids, can 
cause uterine cavity distortion and interfere with implantation (8-11). Genital tract infections 
and endometriosis may result in an endometrial inflammatory response and upper 
reproductive tract scarring, which also hinders conception (12, 13). Luteal phase defects, 
which commonly result in intermenstrual bleeding during the luteal phase, may result in 
dysfunctional endometrial development, which could interfere with implantation or 
maintenance of pregnancy. (14-18).
The association between intermenstrual bleeding and natural fertility has not been 
previously evaluated. As intermenstrual bleeding may represent underlying pathologies 
which could interfere with implantation, we hypothesized that intermenstrual bleeding 
would impair a woman’s fertility. We sought to determine the impact of intermenstrual 
bleeding and luteal bleeding on fecundability, the probability of conceiving in a given cycle, 
in the current cycle and in the next consecutive cycle.
Material and Methods
This is a sub-study within Time to Conceive (TTC), an ongoing time-to-pregnancy study 
approved by the Institutional Review Board of the University of North Carolina. English-
speaking women between 30 and 44 years of age, who were attempting to conceive for 3 
months or less, were eligible for participation in the study. This analysis includes women 
recruited between April 2008 and April 2015. Women were recruited by direct advertising, 
online and on-air marketing strategies. Women with a history of infertility, polycystic 
ovarian disease, pelvic inflammatory disease, endometriosis, pelvic radiation, or with a 
partner with a history of infertility were excluded from participation. After informed consent 
was obtained, women completed a baseline questionnaire, which included survey of 
demographics, height, weight, and medical history for both the participant and her partner 
and of behaviors such as tobacco, alcohol, and caffeine use. The baseline questionnaire also 
queried duration of pregnancy attempt by asking specific questions regarding prior birth 
control methods: type, duration of use in the past year, and date of cessation; date participant 
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started having intercourse without preventing pregnancy; and number of menstrual cycles at 
risk for pregnancy.
While attempting to conceive, women recorded information in a daily diary and were 
subsequently followed without intervention until pregnancy was detected. The daily diary 
included information on vaginal bleeding or spotting (as reported by women without any 
specific definition or instruction), markers of ovulation (cervical mucus scores, temperature, 
and ovulation test results), acts of intercourse, and pregnancy test results. Women provided 
daily data for up to four months if no positive pregnancy test occurred. If women were not 
pregnant after the fourth month, a monthly diary was completed for the remainder of the 
study, up to 12 months, or until pregnancy was achieved. Women were provided free home 
pregnancy tests, with a sensitivity of 20 mIU human chorionic gonadotropin (hCG) per mL, 
and standardized pregnancy testing instructions. Specifically, women were instructed to test 
for pregnancy on days 28, 31, and 34 of their cycles if they did not have menstrual bleeding.
Definitions
Menses was defined as 3 or more days of bleeding or spotting (with at least one day of 
bleeding), followed by 2 consecutive days without bleeding or spotting. The first day of a 
cycle was defined as the first day of bleeding occurring during menses. Bleeding episodes 
(including both “bleeding” and “spotting” observations reported in the daily diary), which 
did not meet the definition of a menses or began prior to cycle day 20, were classified as 
intermenstrual bleeding. Luteal bleeding, a subset of intermenstrual bleeding, was defined as 
any non-menstrual bleeding episode, which occurred during the luteal phase. Ovulation was 
estimated to have occurred on day after a positive ovulation predictor test result. If ovulation 
tests results were not available, then ovulation was defined as either the last day of type 4 
cervical mucus or 14 days prior to the first day of menses or reported pregnancy. In coding 
the bleeding variables, we included only cycles 21-35 days in length in attempt to exclude 
anovulatory cycles. For modeling, cycles were only included if entries were made for all 
days in the cycle or if intermenstrual bleeding was noted in an incomplete cycle. Cycles with 
missing data and no intermenstrual bleeding were coded as missing.
Bivariate analyses were conducted to compare women based on their intermenstrual and 
luteal bleeding patterns in their first study cycle. Fisher’s exact test and the Kruskal-Wallis 
test were used to evaluate relationships between potential covariates and intermenstrual or 
luteal bleeding for categorical and continuous variables, respectively. Subsequently, discrete-
time Cox proportional hazards models with time-varying (cycle-specific) exposure variables 
were created to determine the impact of either intermenstrual bleeding or luteal bleeding on 
probability of pregnancy in that cycle (current cycle fecundability) and in the next cycle 
(subsequent cycle fecundability). These models account for both right censoring and left 
truncation (due to women enrolling in cycles 1, 2, 3 or 4 or their pregnancy attempt), which 
were present in the data. In this model, a fecundability ratio (FR) of less than 1.0 suggests 
reduced fecundability. To adjust for potential confounders, covariates were added to the 
models. The full model was reduced to include only covariates strongly predictive of 
pregnancy in our cohort or in prior studies. Adjusted Kaplan-Meier curves were also created 
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using the intermenstrual and luteal bleeding status in the first cycle as the exposure of 
interest.
Model 1 included the following covariates: age, race, body mass index (BMI), gravidity, 
mean cycle length, education level and smoking. Maternal age was modeled with 3 
categories (<35 years, 35-37 years and >37 years), education level was categorized into 4 
groups (less than a college degree, college graduate, some graduate level work, and 
graduate/professional degree), and BMI was categorized into 4 groups: underweight (<18.5 
kg/m2), normal (≥18.5 and <25 kg/m2), overweight (≥25 and <30 kg/m2), and obese (≥30 
kg/m2), In an attempt to more clearly delineate the impact of an isolated episode of 
intermenstrual or luteal bleeding on subsequent fecundability, model 2 included all variables 
in model 1 in addition to adjusting for intermenstrual bleeding in the outcome cycle. Thus, 
model 1 evaluates the impact of intermenstrual bleeding in a cycle on pregnancy outcome in 
the subsequent cycle, regardless of the presence or absence of intermenstrual bleeding in the 
outcome cycle. In comparison, model 2 evaluates the impact of intermenstrual bleeding in a 
cycle on pregnancy outcome in the subsequent cycle, adjusted for presence or absence of 
intermenstrual bleeding in the outcome cycle.
Results
A total of 1,552 cycles from 575 women were included in this analysis, with 196 cycles 
containing missing data on bleeding. Sixty-one percent of women enrolled in the study 
become pregnant, and 249 women (43%) conceived during the daily diary portion of the 
study. Fecundability in the first cycle of attempt was 18%. Although the study enrolled 
women between 30 and 45 years of age, 68% of the participants were less than 35 years of 
age, 19% between 35 and 37 years of age, and 13% 38 years or older. Participants tended to 
be Caucasian (77%) and highly educated (63% with a graduate degree). The majority of 
women had a normal BMI (60%), while 3% were underweight and 37% were overweight or 
obese.
In the first observed cycle, 38% and 34% of women had intermenstrual and luteal bleeding, 
respectively. Further, intermenstrual and luteal bleeding was reported in 36% and 34% of all 
observed cycles, respectively. Ninety-three percent of all intermenstrual bleeding was luteal 
bleeding. Figure 1 depicts the number of days of intermenstrual and luteal bleeding per 
woman in the first observed cycle. Of women who contributed at least 2 cycles, 51% of 
those who had intermenstrual bleeding in the first cycle also had intermenstrual bleeding in 
the subsequent cycle. No significant differences in baseline characteristics were observed 
between women who had intermenstrual or luteal bleeding in the first observed cycle and 
those who did not (Table 1).
Both unadjusted and adjusted cycle-specific fecundability ratios revealed lower current cycle 
fecundability in cycles with intermenstrual bleeding but higher subsequent cycle 
fecundability in cycles with intermenstrual bleeding (Table 2). Cycles in which women had 
either intermenstrual or luteal bleeding were significantly less likely to result in conception, 
with an adjusted FR of 0.23 (95% CI: 0.16-0.34) and 0.22 (95% CI: 0.14-0.33), respectfully 
(model 1). Cycles in which women had intermenstrual or luteal bleeding were associated 
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with an increase in probability of conception in the subsequent cycle, with an adjusted FR of 
1.61 (95% CI: 1.15-2.25) and FR=2.01 (95%CI:1.52-2.87), respectively, in the fully adjusted 
model (model 2).
Adjusted Kaplan-Meier curves with 95% CI demonstrated that the cumulative probability of 
pregnancy over 12 months was not different for women who had intermenstrual bleeding 
and those without intermenstrual bleeding in the first observed cycle (Figure 2). Although 
women with intermenstrual bleeding in the first observed cycle had slightly lower fertility 
for approximately the first 6 months of conception attempt, by 12 months there was no 
significant difference in cumulative probability of pregnancy nor were the curves statistically 
significantly different (p=0.29). Further, for luteal bleeding, the curves are very similar 
throughout the 12 months, also without significant statistical difference (p=0.64).
Discussion
Intermenstrual bleeding was relatively common in our cohort, and the vast majority of 
intermenstrual bleeding occurred in the luteal phase. Intermenstrual bleeding was not 
associated with any specific patient characteristics. Women who had an episode of 
intermenstrual bleeding were significantly less likely to conceive in that same cycle. 
However, an episode of intermenstrual bleeding did not decrease the probability of 
pregnancy in the subsequent cycle. In fact, intermenstrual bleeding was associated with an 
increase in probability of conception in the next consecutive cycle. Further, one episode of 
intermenstrual bleeding did not result in any difference in probability of conception after 12 
months.
Our prospective observation demonstrates that both intermenstrual bleeding and luteal 
bleeding are relatively common in women trying to conceive. More than ninety percent of 
bleeding episodes occur in the luteal phase. Previous studies have reported that between 
5-13% of women have intermenstrual bleeding (5-7). In a population of women trying to 
conceive, Mikolajczyk et al. reported that 8% of their cohort (total n=74) had non-menstrual 
bleeding (6). However, the authors disclose that many more bleeding episodes were defined 
which were likely non-menstrual but were not recognized as such by the participants, likely 
underestimating the true prevalence of intermenstrual bleeding. Dasharathy et al. reported 
that 4.8% of women (total n=259) reported having non-menstrual bleeding (7). However, 
this may under represent the general population as an inclusion criteria for the study was 
regular menstrual cycles and patients with intermenstrual bleeding may interpret their cycles 
as irregular. Another evaluation of menstrual cycles characteristics reported that 13.3% of 
reproductive aged women had intermenstrual bleeding based on a single administration of a 
questionnaire (total n=3,941) (5). The prevalence of intermenstrual bleeding in our cohort is 
higher than previously reported. Our study may differ from others based on our definition of 
intermenstrual bleeding. In our study, premenstrual spotting, even as little as one day of 
spotting prior to menses, was considered intermenstrual bleeding. In addition, women were 
queried daily with regard to bleeding or spotting, which may have resulted in a higher 
response rate when compared to other methods of ascertainment. Despite this difference, 
intermenstrual bleeding appears to be relatively common in women trying to conceive.
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Intermenstrual bleeding was associated with a lower probability of pregnancy in the current 
cycle. In IVF cycles, luteal bleeding has been shown to be a poor prognostic sign for 
conception in the current cycle. A secondary analysis of a randomized trial (n=365) revealed 
that women with luteal bleeding after IVF were less likely to achieve pregnancy than women 
without bleeding (45% versus 74%, respectively) (19). In this study, women who did get 
pregnant but had luteal bleeding were also more likely to have a failing pregnancy than those 
who did not have bleeding (50% versus 27%, respectively) (19). A cross-sectional, survey 
study found that women with intermenstrual bleeding were more likely to have a history of 
infertility (5). Our study differs in 1) the exposure: an episode of intermenstrual bleeding 
versus history of intermenstrual bleeding, 2) the outcome: fecundability versus history of 
infertility and 3) study design: prospective cohort versus cross-sectional.
An episode of intermenstrual bleeding did not reduce the probability of pregnancy in the 
next consecutive cycle. In fact, an isolated episode of intermenstrual bleeding was associated 
with an increase in the probability of conception in the subsequent cycle. When controlling 
for intermenstrual bleeding in the outcome cycle, this association was even more 
pronounced. Intermenstrual bleeding may represent undetected early pregnancy loss. Wilcox 
et al. evaluated a cohort of women attempting pregnancy (n=221) and reported an incidence 
of unrecognized early pregnancy loss of 22%, the majority of which had hCG levels which 
would escape detection on standard urinary pregnancy tests (20, 21). The mean cycle length 
in cycles with unrecognized pregnancy loss was 32 days (as compared to 29 days in cycles 
without a loss), thus menses was not markedly disturbed by the failed pregnancy (21). 
Although our data did not show a difference in mean cycle length between women who had 
intermenstrual bleeding and those who did not, we did restrict our cohort to cycles less than 
35 days in length in an attempt to exclude anovulatory cycles from the analysis. This may 
have limited our ability to detect a difference in cycle length between cycles with 
intermenstrual bleeding and those without. In addition, a secondary analysis of the cohort 
from Wilcox et al. revealed that the overall pattern of bleeding in patients with an early 
pregnancy loss (<6 weeks) was very similar to normal menses with only a slight increase in 
number of light spotting days in women with pregnancy loss (22). Therefore, very early 
pregnancy loss may be indistinguishable from luteal phase bleeding and menses on the basis 
of bleeding patterns alone.
We hypothesize that the luteal bleeding observed in our cohort may represent unrecognized 
early pregnancy loss. Women with an isolated episode of luteal bleeding may represent a 
more fertile subset of the population. In a prospective cohort of women attempting 
pregnancy (n=221), Wilcox et al. reported that women with an unrecognized pregnancy loss 
were more likely to get pregnant in the next consecutive cycle (35% versus 25% of women 
without a pregnancy) (21). Similar findings have been reported in infertile patients as well. 
Bates et al. reported that in women undergoing IVF (n=1,679), those with a an early loss in 
their first IVF cycle had higher rates a conception in the subsequent cycle over those without 
a pregnancy (37% versus 27%) (23). Croucher et al. evaluated women undergoing a second 
IVF cycle (n=2,396) and found those women with a biochemical pregnancy loss in their first 
cycle were more likely to conceive in their second IVF cycle as compared to women without 
a pregnancy (36% versus 24%) (24). An evaluation of consecutive IVF cycles (n=1,141) also 
revealed that women with a prior pregnancy loss had an increased probability of pregnancy 
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in the subsequent IVF cycle (48% versus 34.5%) (25). Thus, patients with an isolated prior 
early pregnancy loss likely have greater reproductive potential than women who have never 
achieved pregnancy.
When evaluating the impact of one episode of intermenstrual or luteal bleeding on the 
probability of pregnancy we did not observe a significant difference in the cumulative 
pregnancy rate at 1 year (or conversely probability of infertility) for those women who bled 
and those who did not bleed. This study was not designed to examine the impact of 
repetitive episodes of intermenstrual bleeding on fertility. However, considering that 
intermenstrual bleeding was associated with lower fecundability in the current cycle, one 
might deduce that repetitive episodes of intermenstrual bleeding over multiple cycles would 
result in overall lower fertility.
To our knowledge, ours is the first study to examine the impact of intermenstrual and luteal 
phase bleeding on subsequent fertility in a population of unproven reproductive potential. 
Our study does have limitations. The cohort was composed of mostly Caucasian, well-
educated, and older women. These findings may not be generalizable to other groups. Also, 
detection bias may be present due to our pregnancy testing protocol. Women in our study 
were instructed to test for pregnancy on days 28, 31, and 34 of their cycles if they did not 
have menstrual bleeding. Thus, as women with intermenstrual bleeding, and specifically 
luteal bleeding, may have perceived this bleeding as the onset of a new cycle and not tested 
for pregnancy. Strengths of this study include the size of the cohort, modeling with 
adjustment for potential confounders, and the prospective nature of this study in a non-
infertile population trying to conceive. Furthermore, recall bias was reduced by use of the 
daily diary to record bleeding.
In summary, our study reveals that an episode of intermenstrual bleeding significantly 
decreases the odds of conception in the current cycle; however, it does not appear to impact 
a woman’s future reproductive potential. The increase in subsequent cycle fecundability 
seen with luteal bleeding could be due to an early, unrecognized pregnancy loss and 
represent a more fertile segment of the population. Therefore, in ovulatory patients with a 
single episode of luteal bleeding, expectant management is likely the best course of action as 
many will conceive without intervention in subsequent attempt cycles.
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Figure 1. 
Number of days of intermenstrual bleeding (A) and luteal bleeding (B) in the first observed 
cycle (a total of 549 first observed cycles)
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Figure 2. 
Adjusted Kaplan Meier curves by intermenstrual bleeding (A) and luteal bleeding (B) in the 
first observed cycle.
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Table 2
Cycle-specific fecundability ratios (FR)* for patients with intermenstrual bleeding
Unadjusted FR (95% CI) Adjusted FR1 (95% CI) Adjusted FR2 (95% CI)
Current cycle fecundability
 Intermenstrual bleeding 0.22 (0.15-0.32) 0.23 (0.16-0.34)
 Luteal bleeding 0.21 (0.14-0.31) 0.22 (0.14-0.33)
Subsequent cycle fecundability
 Intermenstrual bleeding 1.20 (0.91-1.58) 1.25 (0.94-1.66) 1.61 (1.15-2.25)
 Luteal bleeding 1.36 (1.04-1.77) 1.46 (1.11-1.91) 2.01 (1.52-2.87)
*
Based on a Cox proportional hazards model
1
Model 1: adjusted for age, race, education level, gravidity, smoking, BMI, and mean cycle length with absence of bleeding as the reference group.
2
Model 2: adjusted for bleeding in the outcome cycle in addition to all variables adjusted for in model 1, with absence of bleeding as the reference 
group.
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